N
orth American Sterilization & Packaging Company
17 Park Drive, Franklin, New Jersey 07416 USA
Phone:1.973.209.4388    1.800.392.6310       Fax:1.973.209.6374        Email: info@naspco.com

Home Page About NASP Virtual Tour Inquiries Search FAQ News

 


NASP News

North American Sterilization & Packaging Company, Inc. Establishes Internet Presence
      See the Press Release for more details.   

Press Releases

These are the press releases we've issued over the last year. You may want to search for topics by keyword.

Recent Technical Publications by North American Sterilization & Packaging Company, Inc.

  • Optimizing EtO Sterilization
    The use of ethylene oxide (EtO) gas has long been a dominant mode of terminal sterilization. Today, close to half of all medical devices produced in the United States are processed with EtO. But while it remains a popular method of sterilization, the pressures of global competition demand greater cost-effectiveness and flexibility of the process. At the same time, compliance with regulatory requirements must be maintained.
  • EtO Sterilization: Microbiological Aspects of Process Validation
    Deliberate decision making during the structuring of microbial challenges, product loads, and biological indicators can provide a validation process for EtO sterilization that ensures accuracy, the absence of microbes, and a smooth testing procedure.
  • EtO Sterilization: Principles of Process Design
    By following a structured method, process engineers can design and validate safe and efficacious EtO sterilization cycles.
  • Speeding EtO-Sterilized Products to Market with Parametric Release
    The difficulty of measuring EtO and water vapor during processing has been a major obstacle to adoption of parametric release by EtO sterilizers, but the latest gas analysis techniques are making in-process monitoring and control possible.
  • Biocompatibility Testing Is Needed Despite Material Supplier Claims
    When selecting materials, medical device manufacturers must perform biocompatibility tests, even if material suppliers claim their materials are biocompatible.
  • Evaluating Sterilizer Performance as Part of Process Equivalency Determination
    Medical device manufacturers that use ethylene oxide (EtO) to sterilize their products, either in-house or at a contract sterilizer, often validate the cycle in one particular vessel and later find it no longer satisfies their requirements. A validated vessel becomes outgrown when the number of devices manufactured per week exceeds its volumetric sterilization capacity.
  • Investigating and Preventing BI Sterility Failures
    Because microbiological destruction is logarithmic and therefore can only be expressed in terms of the probability of a survivor, the term sterile device does not actually refer to a device that is totally free of viable organisms, but rather to one whose probability of containing a viable organism is so small that it is considered acceptable. Hence the use of the sterility assurance level (SAL) to describe the degree of sterility of a device.
  • Parametric Release Comes To ETO Sterilization
    After decades of anguishing over long aeration times and interminable incubation periods, manufacturers of medical devices sterilized with ethylene oxide (EtO) may finally be getting something of a break. Thanks to the efforts of industry experts in the United States and abroad, significant attention is now being paid to the possible use of parametric release for EtO-sterilized devices.

 

 

Your NASP Team Access USA New Member New Website

This website is designed for monitors with a resolution of 1024 x 768
and
to be viewed with MS Internet Explorer or Netscape Navigator Web Browsers
Send mail to fdpp@fdpp.com with questions or comments about this web site.
Copyright © 2001 North American Sterilization & Packaging Company, Inc.